€0.24
-5.95%
Compare
IIntegragen S.A vs Abivax SAAIIntegragen S.A vs NanobiotixNIIntegragen S.A vs Abionyx Pharma S.AAIIntegragen S.A vs Innate Pharma S.AIIIntegragen S.A vs Maat Pharma S.A.C.AMIIntegragen S.A vs CAC 40 | MarketC

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Income Metrics

Balance Sheet Metrics

Total Assets 6.2M
Total Liabilities 4.3M
Shareholders Equity 1.9M
Debt to Equity 2.28

Cash Flow Metrics

Revenue & Profitability Trend

Annual Income Flow i

Integragen S.A Income Statement From 2019 to 2023

Metric 2023 2022 2021 2020 2019
Revenue i 12.5M 13.2M 11.3M 9.0M 8.3M
Cost of Goods Sold i 7.5M 8.4M 7.2M 5.5M 4.7M
Gross Profit i 5.0M 4.7M 4.1M 3.4M 3.6M
Gross Margin % i 40.0% 36.0% 36.6% 38.3% 43.1%
Operating Expenses
Research & Development i - - - - -
Selling, General & Administrative i - - - - -
Other Operating Expenses i 400.9K 392.3K 1.5M 1.3M 396.8K
Total Operating Expenses i 400.9K 392.3K 1.5M 1.3M 396.8K
Operating Income i -117.6K -69.2K -69.5K -168.5K -339.5K
Operating Margin % i -0.9% -0.5% -0.6% -1.9% -4.1%
Non-Operating Items
Interest Income i 64.1K 9.3K 2.0K 3.4K 39.7K
Interest Expense i 8.4K 11.9K 4.9K 5.2K 2.6K
Other Non-Operating Income - - - - -
Pre-tax Income i -259.1K -143.5K -114.3K -467.4K -437.9K
Income Tax i -87.7K -140.0K -129.7K -92.4K -153.1K
Effective Tax Rate % i 0.0% 0.0% 0.0% 0.0% 0.0%
Net Income i -171.4K -3.5K 15.4K -375.0K -284.8K
Net Margin % i -1.4% -0.0% 0.1% -4.2% -3.4%
Key Metrics
EBITDA i 168.4K 141.6K 62.1K -43.0K -43.5K
EPS (Basic) i €-0.03 €0.00 €0.00 €-0.06 €-0.04
EPS (Diluted) i €-0.03 €0.00 €0.00 €-0.06 €-0.04
Basic Shares Outstanding i 6613144 6627982 6618794 6704136 6551669
Diluted Shares Outstanding i 6613144 6627982 6618794 6704136 6551669

Income Statement Trend

Integragen S.A Balance Sheet From 2019 to 2023

Metric 2023 2022 2021 2020 2019
Assets
Current Assets
Cash & Equivalents i 1.8M 2.5M 2.9M 1.0M 1.2M
Short-term Investments i 1.0M 2.0M 1.8M 4.1M 1.6M
Accounts Receivable i 3.0M 3.2M 3.4M 2.1M 1.8M
Inventory i 311.4K 386.7K 341.6K 237.7K 289.7K
Other Current Assets - - 8.1K - 77
Total Current Assets i 7.7M 8.6M 9.0M 7.9M 5.7M
Non-Current Assets
Property, Plant & Equipment i 1.5M 1.5M 1.6M 572.4K 1.6M
Goodwill i 0 0 - 0 0
Intangible Assets i - - - - -
Long-term Investments - - - - -
Other Non-Current Assets 141.9K 115.6K 1 2 74.5K
Total Non-Current Assets i 316.1K 468.1K 624.5K 874.3K 1.1M
Total Assets i 8.0M 9.0M 9.6M 8.8M 6.7M
Liabilities
Current Liabilities
Accounts Payable i 1.3M 1.6M 1.8M 901.4K 701.1K
Short-term Debt i 482.5K 508.5K 2.0M 2.0M 241.2K
Current Portion of Long-term Debt - - - - -
Other Current Liabilities - - - - 49.6K
Total Current Liabilities i 5.2M 5.6M 7.1M 6.5M 3.1M
Non-Current Liabilities
Long-term Debt i 642.3K 1.2M 2.0M 3.0K 241.2K
Deferred Tax Liabilities i - - - - -
Other Non-Current Liabilities 34.9K 45.5K 263.6K 62.4K 1.0M
Total Non-Current Liabilities i 834.1K 1.2M 271.7K 118.5K 1.2M
Total Liabilities i 6.0M 6.8M 7.4M 6.7M 4.2M
Equity
Common Stock i 3.4M 3.4M 3.4M 6.7M 6.6M
Retained Earnings i -1.4M -1.2M -1.2M -9.6M -9.3M
Treasury Stock i - - - - -
Other Equity - - - - -
Total Shareholders Equity i 2.0M 2.2M 2.2M 2.2M 2.5M
Key Metrics
Total Debt i 1.1M 1.7M 3.9M 2.0M 482.3K
Working Capital i 2.5M 2.9M 1.8M 1.4M 2.6M

Balance Sheet Composition

Integragen S.A Cash Flow Statement

No cash flow data available.

Integragen S.A Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) -5.92
Price to Book 0.57
Price to Sales 0.16

Profitability Ratios

Profit Margin -23.43%
Operating Margin -53.37%
Return on Equity -138.00%
Return on Assets -23.72%

Financial Health

Current Ratio 1.19
Debt to Equity 119.83
Beta 0.39

Per Share Data

EPS (TTM) €-0.04
Book Value per Share €0.29
Revenue per Share €1.90

Peer Financial Comparison

Company Market Cap P/E Ratio P/B Ratio ROE Profit Margin Debt/Equity
ALINT 1.1M -5.92 0.57 -138.00% -23.43% 119.83
Abivax SA 7.6B -19.88 16.56 -135.58% 0.00% 7.05
Nanobiotix 1.4B - - 28.36% -73.52% -1.13
Abionyx Pharma S.A 128.4M -22.75 23.18 -123.01% -134.15% 0.84
Innate Pharma S.A 108.3M -2.05 - 226.58% 0.00% -1.04
Maat Pharma S.A.C.A 99.9M -2.47 9.69 -511.92% 61.13% 969.43
Nippun Rana

Nippun Rana

Chasing the market trend!

Hi, I’m Nippun, a tech enthusiast from Haryana, India. I have been coding since 2010 and using my coding skills in the share market since 2020. I have been coding scripts in Pinescript that work on Tradingview app/web. I love learning about new technology and applying it to solve real-world problems. Coding and share-market are my passions, and I enjoy finding and fixing bugs in code. I aim to share my skill set and experience that can positively impact society. Feel free to connect with me, an...

Financial data is updated regularly. All figures are in the company's reporting currency.